Abbratech Inc.
Branford, CT Part of Abbratech Holdings LLC
- UEI
- G7S7M6L41EX5
- CAGE
- 8VPC6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Abbratech Holdings LLC
Parent
R4MYMELTMV33
- Abbratech Inc. G7S7M6L41EX5
-
Abbratech Holdings LLC
Parent
R4MYMELTMV33
- SAM.gov registration date
- Physical address
- 25 Business Park Dr Unit C, Branford, CT 06405, USA
- Website
- abbratech.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Abbratech Inc.
Abbratech Inc. is a corporate entity registered in SAM.gov, located in Branford, Connecticut, that specializes in advanced biotechnology research and development, with a particular focus on antibody engineering and innovative molecular biology technologies. As a self-certified small disadvantaged business, the company has developed proprietary platforms for antibody generation, validation, and characterization, with a core technological approach centered around their unique "EpiVolve" phage display technology. The company appears to be primarily engaged in biomedical research, targeting complex challenges in protein analysis, immunotherapy, and diagnostic reagent development.
Through federal grant awards, primarily from the National Institute of General Medical Sciences (NIGMS) and the National Institute of Allergy and Infectious Diseases (NIAID), Abbratech Inc. has pursued multiple research initiatives focused on developing advanced antibody generation platforms. Their grant-funded projects have included developing site-specific antibodies for targeting protein splice variants, creating T-cell receptor mimic antibodies for precision oncology, generating neutralizing antibodies for viral research (including SARS-CoV-2 and Influenza A), and establishing high-throughput methods for antibody validation and production. The company has also engaged in sub-awards with the University of Connecticut Health Center, specifically contributing to anti-treponemal cell surface antibody research by designing peptides, identifying antibodies, performing ELISA and Western analysis, and supporting data analysis for molecular typing and genomics manuscripts. These diverse research efforts demonstrate Abbratech's sophisticated capabilities in molecular biology, immunology, and biotechnology research and development.
Quick answers
What is Abbratech Inc.'s UEI?
Abbratech Inc.'s Unique Entity ID (UEI) in SAM.gov is G7S7M6L41EX5.
What is Abbratech Inc.'s CAGE code?
Abbratech Inc.'s CAGE code is 8VPC6.
What is Abbratech Inc.'s primary NAICS code?
Abbratech Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Abbratech Inc. located?
Abbratech Inc.'s physical address in SAM.gov is 25 Business Park Dr Unit C, Branford, CT 06405, USA.
Is Abbratech Inc. registered in SAM.gov?
Yes. Abbratech Inc.'s SAM.gov registration is active through August 17, 2027.
Who is Abbratech Inc.'s parent company?
Abbratech Inc. is part of Abbratech Holdings LLC.
What is Abbratech Inc.'s most recent federal award?
Abbratech Inc.'s most recent federal grant award is Directed discovery and validation of anti-splice-junction site ABS - abstract this fast track proposal's overarching… (R44GM156476), from National Institute of General Medical Sciences, on September 20, 2024.
On GovTribe
See Abbratech Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors